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Single cell analysisApoptosis signaling crucially depends on caspase activities. Caspase-2 shares features of both initiator and effec-
tor caspases. Opinions are divided on whether caspase-2 activity is established during apoptosis initiation or
execution in response to DNA damage, death receptor stimulation, or heat shock. So far, approaches towards
measuring caspase-2 activity were restricted to analyses in cell homogenates and extracts, yielded inconsistent
results, and were often limited in sensitivity, thereby contributing to controversies surrounding the role of
caspase-2 during apoptosis. Furthermore, caspases overlap in substrate speciﬁcities, and caspase-8 as well as
effector caspasesmay cleave the optimal VDVAD recognitionmotif aswell.We therefore generated a highly sen-
sitive Förster resonance energy transfer (FRET) substrate to determine the relative contribution of these caspases
to VDVADase activity non-invasively inside living cells. We observed limited proteolysis of the substrate during
apoptosis initiation in response to death receptor stimulation by FasL, TNFα and TRAIL. However, this activity
was attributable to caspase-8 rather than caspase-2. Likewise, no caspase-2-speciﬁc activity was detected during
apoptosis initiation in response to genotoxic stress (cisplatin, 5-FU), microtubule destabilization (vincristine), or
heat shock. The contribution of caspase-2 to proteolytic activities during apoptosis execution was insigniﬁcant.
Since even residual, ectopically introduced caspase-2 activity could readily be detected inside living cells in
ourmeasurements, we conclude, in contrast to several previous studies, that caspase-2 activity does not contrib-
ute to apoptosis in the scenarios investigated, and that instead caspase-8 and effector caspases are the most
signiﬁcant VDVADases during canonical apoptosis signaling.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The elimination of damaged and superﬂuous cells by apoptosis is
an essential process during the entire lifetime of all metazoan, and
dysregulated apoptosis sensitivity and apoptosis signal transduction
have been implicated in various proliferative and degenerative dis-
eases [1]. Since apoptosis is initiated in response to a wide range of
different stresses, cells must be able to integrate highly diverse sig-
nals and translate these into an active and coordinated cell death
response. Pro-apoptotic stress signals are received on the outside, for
example through binding of death ligands to their cognate cell surface
receptors, or induce apoptosis through an intracellular-initiated signal-
ing sequence [1]. Extrinsic apoptosis results in the activation of initiator
caspases-8/-10. In some cells, these cysteine proteases can directly
cleave and activate effector caspase-3 and induce apoptosis executionand Department of Physiology
, RCSI York House, York Street,
2 2447.
rights reserved.[2]. However, inmost cells cleavage of the BH3-only protein Bid and ac-
tivation of the mitochondrial pathway are required for apoptosis
execution. Truncated Bid activates the pore forming proteins Bax
and Bak. Intrinsic apoptosis responses are triggered by various stimuli,
including for example genotoxic chemotherapeutics, microtubule
destabilizing agents, impaired protein degradation, heat shock, and
radiation-induced DNA damage. As a consequence, BH3-only proteins,
such as Puma, Bim, Bad andNoxa, are transcriptionally induced, activat-
ed through post-translational modiﬁcation or evade degradation. Like
truncated Bid, these BH3-only proteins activate Bax/Bak and/or antago-
nize anti-apoptotic Bcl-2 proteins [3]. Bax/Bak pores permeabilize the
outermitochondrialmembrane and allow for the release of cytochrome
c and Smac/Diablo into the cytosol [4]. Cytosolic cytochrome c and Smac
trigger an efﬁcient and sequential activation of initiator caspase-9 and
effector caspases-3, -7 and -6. Effector caspases orchestrate the execu-
tion of apoptotic cell death by cleaving hundreds of substrates [5].
While the above mentioned caspases could be positioned unambigu-
ously within the sequence of apoptosis signal transduction, the place-
ment and role of caspase-2 during apoptosis remain contentious [6,7].
Caspase-2 possesses molecular features reminiscent of both initiator
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a caspase activation and recruitment domain (CARD) motif that is also
found in initiator caspase-9, while the substrate speciﬁcity of caspase-2
instead resembles that of effector caspases [8–10]. Unlike other caspases,
which recognize tetrapeptide sequences, caspase-2 requires a pentapep-
tide recognition motif, with VDVAD being the optimal recognition
sequence [11]. However, also caspase-3, and to a lesser extent also
caspase-7, are efﬁcient VDVADases [12], so that VDVADase activity
cannot necessarily be equated with caspase-2 activity. Dimerization
of procaspase-2 is sufﬁcient to establish activity, and dimerization
is followed by autocatalytic cleavage into p37/p13 and p18/p12
heterotetramers (p37/p14 and p19/p12 for murine caspase-2) with
increased catalytic activity [13]. In that respect, the caspase-2 activa-
tion mechanism resembles that of other initiator caspases, such as
caspases-8 and -10. However, since procaspase-2 can also be cleaved by
caspases-8 and -3 without prior dimerization [14], the presence of
processed subunitsmay not necessarily reﬂect caspase-2 activation or ac-
tivity. The primary caspase-2 dimerization and activation platform is con-
sidered to be the PIDDosome, a multiprotein complex consisting of
p53-induced protein with a death domain (PIDD), receptor-interacting
protein-associated ICH-1/CED-3 homologous protein with a death do-
main (RAIDD) and caspase-2 [15,16]. It is thought that multiple copies
of procaspase-2 are coming into close proximity at the PIDDosome, pro-
moting dimerization and activation. However, caspase-2 may also be ac-
tivated independent of PIDD [17,18], indicating that other caspase-2
activation platforms might exist. The problems associated with unequiv-
ocally identifying caspase-2 activation and activity and the determination
of which caspases underlie VDVADase activities, therefore, are manifold.
Previous measurements were either conducted in cell homogenates
and cell extracts, or, in living cells, were restricted to surrogate indicators
such as PIDDosome formation [19]. A direct and speciﬁc determination of
the magnitude and frequency of intracellular VDVADase activities and
their dependence on caspase-2 during apoptosis is therefore still out-
standing. Here, we generated and characterized a VDVAD-based Förster
resonance energy transfer (FRET)-based probe and screened scenarios
of extrinsic and intrinsic apoptosis initiation for which the involvement
of caspase-2 is controversially discussed. This approach allowed us to
determine the contributions of caspase-2, caspase-8 and effector caspases
to VDVADase activities inside individual living cells for the ﬁrst time.
2. Materials and methods
2.1. Reagents
Cisplatin, doxorubicin and vincristine were purchased from
Sigma-Aldrich Ireland Ltd (Dublin, Ireland), 5-FU was from
Calbiochem (Merck Biosciences, Nottingham, UK.), FasL was from
Caltag-Medsystems Ltd. (Buckingham, UK) and TNFα from PeproTech
EC Ltd. (London, UK). STS was from Alexis (San Diego, CA, USA) and
Z-Val-Ala-Asp(O-methyl)-ﬂuoromethyl ketone (zVAD-fmk) was from
Bachem (St Helen's, UK). Human recombinant TRAIL was a generous
gift Carlos RicardoRodrigues dos Reis, University of Groningen. Recombi-
nant caspases-3 and -8 were purchased from BD Pharmingen (Franklin
Lakes, NJ, USA). Recombinant caspase-2 was generated as described
previously [20].
2.2. Molecular cloning and plasmids
pCaspase-2-mCherry and pCaspase-2D152,316,330A-mCherry were
generated through PCR-ampliﬁcation of wt and mutated caspase-2
using the following primers (Invitrogen, Paisley, UK): forward primer,
5′-tgagatctatggccgctgacaggggacgca-3′, reverse primer, 5′-cgccaattgtg
tgggagggtgtcctggga-3′. Products were cleaved using BglII and MunI
and ligated into the BglII-EcoR1site of the pmCherry-N1 plasmid
(Clontech, CA). The mutated caspase-2 was ampliﬁed from the
pGALL-(HIS3)-caspase-2D152,316,330A vector (kindly provided byProfessor Christine Hawkins, Murdoch Children's Research Institute,
Parkville, Australia). Generation of the pSCAT2 and the pSCAT-DEVG
inactive mutant was performed by manipulation of the pSCAT3 vector
[21]. The original DEVD caspase-3 cleavage motif was mutated into
VDVAD and DEVG motifs by PCR-ampliﬁcations using the reverse
primers 5′-ccgctggtaccatctgcgacatcgactccgctgagctcggacgagga-3′ and
5′- ccgctggtaccaccgacctcatctccgctgagctcggacgagga-3′, respectively, in
combination with the forward primer, 5′-tcgacggatccgacgagatggagca
gaagctga-3. Products were then cleaved using BamH1 and KpnI and
ligated into the corresponding sites of pSCAT3. A plasmid for the ex-
pression of a fusion protein of red ﬂuorescent protein and Bcl-xL
was kindly provided by Dr Ingram Iaccarino (Institute of Genetics
and Biophysics, Naples, Italy).
2.3. Cell culture and transfection
MCF-7 breast cancer, HCT-116 human colorectal carcinoma and
HeLa cervical cancer cells were cultivated in RPMI-1640 medium
(Sigma-Aldrich). Mouse embryonic ﬁbroblasts (MEF) were grown in
DMEM, supplementedwith nonessential amino acids and sodiumpyru-
vate. Caspase-2 deﬁcient MEFs and associated wild type MEFs were a
kind gift by Prof Andreas Villunger, University of Innsbruck [17]. All
media were supplemented with 2 mM L-glutamine, 10% (v/v) heat-
inactivated fetal bovine serum, 100 U/ml penicillin and 100 mg/ml
streptomycin (Sigma-Aldrich). Glucose-free RPMI-1640 medium (Gibco,
Biosciences, Dublin, Ireland) was enriched with 10% FBS, 100 U/ml peni-
cillin and 100 mg/ml streptomycin and, when required, with 2 mM
sodium pyruvate. Cells were grown in humidiﬁed atmosphere at 5% CO2
at 37 °C. MCF-7 and HCT-116 cells were transfected using Turbofect
(Fermentas GmbH, St Leon Rot, Germany), HeLa cells and mouse embry-
onic ﬁbroblastswere transfected using Lipofectamine™ 2000 (Invitrogen,
Paisley, UK). Transfections were conducted following the manufacturer's
instructions. Populations stably expressing the SCAT-2 VDVAD
FRET probe were isolated by ﬂuorescence selection. siRNA targeting
procaspase-8 (AAU UCG GAA GAG CAG CUC C[dT], [22]), or scrambled
control siRNA (ACU UAA CCG GCA UAC CGG C[dT]) were transfected
at a ﬁnal concentration of 100 nM. ON-TARGETplus SMARTpool siRNAs
targeting caspase-2 (L-003465) or ON-TARGETplus Non-targeting Pool
(D-001810-10-05) were purchased from Dharmacon RNA technologies
(Medical Supply Co., Dublin, Ireland) and transfected at a ﬁnal concen-
tration of 50 nM.
2.4. Fluorescence spectroscopy
pSCAT2 and the pSCAT-DEVG-expressing HeLa cells were washed
twice in PBS and permeabilized in 50 μM Tris–HCl, pH 7.5, 1 mM
EDTA, 10 mM EGTA, 2 mM MgCl2 and 0,3% Triton X-100 for 10 min at
RT. Samples were then incubated in the presence of recombinant
caspase-2 and 5 mM dithiothreitol at 37 °C for 1 h and subjected to
spectral analysis with an excitation wavelength of 435 nm using a LS
45 ﬂuorescence spectrophotometer (Perkin Elmer,Waltham,MA, USA).
2.5. Measurement of VDVADase activity in native cell extracts
The measurement of caspase-2 substrate cleavage was carried out as
follows. 5 × 105 cells were washed once with ice-cold PBS, resuspended
in 25 μl of PBS and added to a microtiter plate. Cell lysis was accom-
plished by means of snap-freezing. Next, cells were combined with
50 mMVDVAD-AMC (Peptide Institute, Osaka, Japan), dissolved in stan-
dard reaction buffer (100 mMHepes, pH 7.25, 10% sucrose, 10 mMDTT,
0.1% CHAPS). Cleavage of the ﬂuorogenic peptide substrate was moni-
tored by AMC liberation in a Fluoroscan II plate reader (Thermo Electron
Co., Waltham, MA, USA) using 355 nM excitation and 460 nM emission
wavelengths. Fluorescence units were converted to pmol of AMC using
a standard curve generated with free AMC. Data from triplicate samples
were then analyzed by linear regression.
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Cells were placed in a water bath preheated to 45 °C for 1 h. Imme-
diately afterwards, cells were washed with phosphate-buffered saline
(PBS) and fresh media was added. Cells were then kept at 37 °C and
5% CO2 for the times indicated. Pre-treatment with 100 μM zVAD for
1 h was used at conditions of caspase inhibition.
2.7. Preparation of whole cell extracts and western blotting
Cellswere collected at 1000 rpm for 3 min andwashedwith PBS. The
cell pellet was resuspended in lysis buffer (62.5 mM Tris–HCl, pH 6.8,
10% (v/v) glycerine, 2% (w/v) SDS, 1 mMphenylmethylsulfonyl ﬂuoride,
1 μg/ml pepstatin A, 1 μg/ml leupeptin, and 5 μg/ml aprotinin) and heat-
ed at 95 °C for 20 min. Protein content was determined with the Pierce
Micro-BCA protein assay (Pierce). An equal amount of protein (20 μg)
was loaded onto SDS-polyacrylamide gels. Proteins were separated at
100 V for 2.5 h and then blotted to nitrocellulose membranes (Protean
BA 83; 2 μm; Schleicher & Schuell) in transfer buffer (25 mM Tris,
192 mM glycine, 20% methanol (v/v), and 0.01% SDS) at 18 V for
60 min. The blots were blocked with 5% nonfat dry milk in TBST
(15 mM Tris–HCl, pH 7.5, 200 mM NaCl, and 0.1% Tween 20) at room
temperature for 1 h. Membranes were incubated with the following
antibodies: A mouse monoclonal caspase-2 antibody (#611023, BD
Biosciences Clontech, Oxford,UK), a rat monoclonal caspase-2 antibody
(#ALX-804-35, 11B4, Enzo Life Sciences Ltd., Exeter, UK), amousemono-
clonal caspase-3 antibody (#610322, Transduction laboratories), a rabbit
polyclonal caspase-3 antibody (#9662, Cell Signaling Technology,
Danvers, MA, USA), a rabbit polyclonal caspase-9 antibody (#6E6808,
Pharmingen), amousemonoclonal green ﬂuorescent protein (GFP) anti-
body (#PC408, Calbiochem/Merck Bioscience, Nottingham,UK), amouse
monoclonal GFP (#11814460001, Roche Applied Science), a mouse
monoclonal human Hsp70 protein (#ADI-SPA-810, Enzo Life Sciences
Ltd., Exeter, UK), a rabbit polyclonal caspase-7 antibody (#9492, Cell Sig-
naling Technology, Danvers, MA, USA), a mouse monoclonal β-actin
antibody (#A5441, Sigma-Aldrich), a mouse monoclonal porin antibody
(Calbiochem Merck Biosciences) a mouse monoclonal anti-α-Tubulin
antibody (#T6199, Sigma-Aldrich), a rabbit polyclonal glyceraldehyde-
3-phosphate dehydrogenase antibody (Nordic Biosite, Täby, Sweden).
Mouse and rabbit IgG peroxidase conjugated secondary antibodies
(AP124P, AP132P, Millipore) were used at a dilution of 1:10,000 for
1 h. Membranes were washed with TBST three times for 5 min and
incubated with mouse or rabbit peroxidase-conjugated secondary IgG
antibodies (Jackson Laboratories) for 1 h. Blots were washed and devel-
oped using enhanced chemiluminescence detection reagent (Amersham
Biosciences). Chemiluminescence was detected at 12-bit dynamic range
using a Fuji LAS 3000 CCD system (Fujiﬁlm UK Ltd., Bedfordshire, UK).
2.8. Flow cytometry
FRET ﬂow cytometry was carried out using a BD LSRII ﬂow
cytometer (Oxford, UK) equipped with 405 nm, 488 nm and 561 nm
lasers. Cells were seeded into 6-well plates (5 × 104 cells per well)
and treated as described. Cell death was assessed by the uptake of
propidium iodide (PI, 2 μg/ml in PBS) into non-ﬁxed cells after incuba-
tion for 20 min at room temperature in the dark and at least 5000 gated
eventswere acquired for each sample. For FRETmeasurements, CFPwas
excited with the 405 nm laser and ﬂuorescence emission was detected
through 450/50 band pass ﬁlters. YFP was excited with the 488 nm
laser and ﬂuorescence emission was collected through 525/50 nm
band pass ﬁlters. Resonance Energy Transfer between CFP and YFP
was determined by detecting YFP emission through the 585/42 nm
band pass ﬁlter upon CFP excitation. Propidium iodide or RFP were
excited with a 561 nm laser and ﬂuorescence emission was detected
through a 605/40 band pass ﬁlter. Data was acquired in.fcs ﬁle formatand analysis was performed using Cyﬂogic (Version 1.2.1, CyFlo Ltd,
Turku, Finland) software.
3. Results
3.1. Generation and characterization of a FRET probe for the measure-
ment of VDVADase activities
Probes consisting of green ﬂuorescent protein variants that are
spectrally suited for FRET measurements have successfully been
used by us and others to measure the activities and activation times
of initiator and effector caspases in living cells previously [23–27].
Here we generated a CFP–YFP FRET probe containing the optimal
caspase-2 cleavage motif VDVAD (SCAT-2) [11]. Proteolytic cleavage
separates donor and acceptor ﬂuorophores, disrupts resonance energy
transfer and increases CFP ﬂuorescence quantum yield (Fig. 1A),
allowing the use of the CFP/FRET ratio as a readout for VDVADase acti-
vation. As expected, recombinant active caspase-2 resulted in VDVAD
probe cleavage and augmented CFP emission, whereas this was not ob-
served when expressing an uncleavable (DEVG) FRET probe (Fig. 1B,C).
Of note, in vitro the probe was also cleaved efﬁciently by caspase-3,
indicating that this effector caspase also exerts signiﬁcant VDVADase ac-
tivity (Fig. 1D). Likewise, also caspase-8 could contribute to probe cleav-
age, albeit far less efﬁciently (Fig. 1D). These data correspond to previous,
more detailed quantitative analyses which demonstrated that both
caspase-2 and -3, as well as caspase-7, are efﬁcient VDVADases, whereas
the proteolytic activity of caspase-8 towards VDVAD motifs is much
lower [12].
We next investigated whether caspase-2 can cleave the probe
in cellulo. Since caspase-2 can only cleave its own precursor, but not
other caspases [14,28], we used MCF-7 cells over-expressing Bcl-xL
(MCF-7 Bcl-xL) to isolate caspase-2 auto-activation and activity from
caspases that otherwise are activated through the mitochondrial apo-
ptosis pathway (Fig. 2A). We then carefully elevated the amount of
procaspase-2 in these cells by ectopic expression (Fig. 2B). Thiswas suf-
ﬁcient to induce limited caspase-2 processing and activation, which
nevertheless resulted in the efﬁcient cleavage of the VDVAD FRET
probe in MCF-7 Bcl-xL cells (Fig. 2C). Spontaneous caspase-2 dimeriza-
tion, processing and activation correspondingly were reported by
others in related experimental settings before [9,10,13]. We also intro-
duced a caspase-2 cleavage mutant (caspase-2D152,316,330A) (Fig. 2B)
which was shown to exhibit signiﬁcantly reduced activity [29]. Using
this mutant, fully cleaved probe could no longer be detected in MCF-7
Bcl-xL cells (Fig. 2C). However, residual and submaximal probe cleavage
was clearly detected upon caspase-2D152,316,330A expression, as seen
by a slight shift in the CFP/FRET ﬂuorescence ratio (Fig. 2D, blue
histogram). Limited amounts of caspase-2 p37 that were observed by
immunoblotting (Fig. 2B) could indicate hetero-dimerization with the
cell-intrinsic pool of caspase-2, as was previously also shown in exper-
iments with a catalytic site mutant of caspase-2 [13]. Taken together,
our data therefore show that caspase-2 can cleave the VDVAD FRET
probe in vitro and in cellulo, and that ourmeasurements are of sufﬁcient
sensitivity to detect both high as well as very low and residual amounts
of intracellular VDVADase activity. Of note, the FRET probe distributed
homogeneously throughout the cytosol and nucleus (as conﬁrmed by
confocal microscopy; data not shown), which ensures that the FRET
substrate is available to caspase-2 at all times, and that proteolysis can
be detected irrespective of the subcellular origin of VDVADase activity.
3.2. Caspase-2 does not contribute signiﬁcantly to VDVAD cleavage
during apoptosis execution
Since it has been suggested that caspase-2 can act as an effector
caspase [30,31], we next determined the contribution of caspase-2 to
VDVADase activities during apoptosis execution. Staurosporine (STS),
a broad spectrum kinase inhibitor, induces the intrinsic apoptosis
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activity in HeLa cells within a few hours (Fig. 3A). Manifestation of
VDVADase activity coincided with probe cleavage (Fig. 3B). Corre-
sponding to the activation of the intrinsic pathway, the amounts of
procaspases-9 and -3 dropped, and the p37 cleavage fragment of
procaspase-2 was detected (Fig. 3C). Caspase-3, and to a lesser extent
caspase-7, can cleave procaspase-2 [14], and previous in vitro character-
izations indicated that both could also directly contribute to VDVAD
probe cleavage during apoptosis execution [12]. We, therefore,analyzed STS-induced FRET probe cleavage in caspase-3 deﬁcient
MCF-7 breast cancer cells and MCF-7 cells in which caspase-3 expres-
sion was re-established (Fig. 3D). The full length FRET probe was lost
irrespective of presence or absence of caspase-3. The cleaved fragments
of the FRET probe seemed to be stabilized in caspase-3-reconstituted
MCF-7 cells (Fig. 3D), possibly due to caspase-3-dependent inactivation
of proteasomal protein degradation [32]. A similar stabilizationwas also
observed for cleaved fragments of a caspase-3/-7-optimized DEVD FRET
probe (Fig. 3E). As expected, FRET probe cleavage correlated in time
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(Fig. 3F-H). We next depleted procaspase-2 in MCF-7 cells to measure
its contribution to FRET probe proteolysis during apoptosis execution.
Lack of procaspase-2 did not reduce probe cleavage, as demonstrated
by FRET ﬂow cytometry (Fig. 3I). Taken together, these measurements
demonstrate that depletion of caspase-2 does not affect VDVAD sub-
strate cleavage. The contribution of caspase-2 to intracellular VDVADase
activity during apoptosis execution is, therefore, negligible.
3.3. FRET-based cytometric screening for VDVADase activity during
apoptosis initiation
In the following we analyzed whether VDVADase activities could
be observed during apoptosis initiation, upstream of apoptotic mito-
chondrial engagement, and whether these activities are attributable
to caspase-2. A considerable number of contradictory studies was
published to address the question whether caspase-2 activity does
contribute to apoptosis initiation in response to intrinsic and extrinsic
pro-apoptotic stimuli (reviewed in [6]). These include genotoxic
drugs such as cisplatin, doxorubicin, 5-ﬂuorouracil (5-FU), inhibitor
of microtubule assembly vincristine, and also extrinsic apoptosis in
response to death ligands. We conducted ﬂow cytometric cell death
and FRET disruption screens to identify whether caspase-2 is activated
in response to these stimuli.
To limit our screen for VDVADase activity to the apoptosis initia-
tion phase, we employed MCF-7 cells stably over-expressing Bcl-xL
and Bax/Bak deﬁcient HCT-116 cells. Both MCF-7 and HCT-116 cells
express all proteins required for PIDDosome-dependent caspase-2
activation, and have been used to investigate caspase-2 signaling in
response to various stimuli before [33–35]. Furthermore, MCF-7 and
HCT-116 cells express wild type p53, and p53 has been suggested to
be required for caspase-2 activation in response to DNA damage[35,36]. Since MCF-7 cells do not express caspase-3, potential contri-
butions to FRET probe cleavage from type-I caspase-3 activation in
response to death ligands could be excluded as well in these cells.
In MCF-7 cells, Bcl-xL efﬁciently suppressed cell death, as mea-
sured by lack of propidium iodide uptake, in response to cisplatin,
5-FU, vincristine, tumor necrosis factor-related apoptosis inducing
ligand (TRAIL), tumor necrosis factor α (TNF), Fas ligand (FasL), and
STS (Fig. 4A,B). MCF-7 cells did not notably respond to doxorubicin.
Bcl-xL expression, therefore, was sufﬁciently high to uncouple the
apoptosis initiation phase from subsequent effector caspase activa-
tion and apoptosis execution. We next screened MCF-7 and MCF-7
Bcl-xL cells for VDVADase activity. As would be expected, VDVADase
activity was established in parental MCF-7 cells in response to all
drugs tested, except for doxorubicin (Fig. 4C,D), and, since VDVADase
activation precedes cell death, the percentages of FRET negative cells
exceeded the amounts of PI positive cells at early time points. In con-
trast, only very small subpopulations of MCF-7 Bcl-xL cells presented
a fully cleaved FRET probe (Fig. 4C,D). Comparable results were
obtained when using HCT-116 cells, where Bax/Bak deﬁciency signif-
icantly reduced cell death (Fig. 5A,B). Similarly, the amount of cells
presenting with fully cleaved VDVAD FRET probe was reduced in
absence of Bax and Bak (Fig. 5C,D). However, VDVADase activity
was not fully prevented after cisplatin, 5-FU, vincristine and TRAIL
treatments (Fig. 5C,D). The results demonstrate that blocking the mi-
tochondrial apoptosis pathway in most scenarios eliminates VDVAD
FRET probe cleavage and that for treatments in which populations
with cleaved probe could still be detected, VDVADases are activated
upstream of apoptotic mitochondrial engagement. We therefore
proceeded to analyze whether complete substrate cleavage in these
subpopulations depended on caspase-2. Depletion of caspase-2 by
siRNA did not reduce the FRET negative populations in MCF-7 Bcl-xL
cells (Fig. 6A, Supplemental Fig. 1) or HCT-116 Bax/Bak deﬁcient
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2284 M.E. Delgado et al. / Biochimica et Biophysica Acta 1833 (2013) 2279–2292cells (Fig. 6B, Supplemental Fig. 1). Even though siRNA-based caspase-2
depletionwas very efﬁcient, it cannot be excluded that residual amounts
of caspase-2 still remained and contributed to probe cleavage.We there-
fore also investigated VDVAD FRET probe cleavage in wild type and
caspase-2 deﬁcient MEFs. MEFs responded well to cisplatin and 5-FU,
and the loss of caspase-2 did not affect FRET probe cleavage (Fig. 6C).
We also over-expressed a red ﬂuorescent Bcl-xL variant in these cellsto investigate VDVADase activity during apoptosis initiation. VDVADase
activity was eliminated in wild type MEFs and signiﬁcantly reduced in
caspase-2 deﬁcient MEFs (Fig. 6C). These results therefore further con-
ﬁrm our ﬁnding that caspase-2 does not contribute to VDVADase activity
during apoptosis initiation.
Interestingly, we found that depletion of caspase-8 reproducibly
reduced probe cleavage in response to TNFα in MCF-7 Bcl-xL cells
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2285M.E. Delgado et al. / Biochimica et Biophysica Acta 1833 (2013) 2279–2292(Fig. 6D) and after cisplatin and vincristine in HCT-116 Bax/Bak deﬁ-
cient cells (Fig. 6E). Full probe cleavage in these small subpopulations
is therefore independent of caspase-2 and may reﬂect cells that initi-
ate apoptosis execution despite Bcl-xL overexpression or Bax/Bak
deﬁciency. The involvement of caspase-8 in apoptosis induced bygenotoxic stress has been reported recently, and may explain the
reduction in probe cleavage in response to cisplatin in HCT-116 cells
[37].
We also considered the possibility that VDVADase activitymayman-
ifest only transiently during apoptosis initiation, and that VDVADase
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2286 M.E. Delgado et al. / Biochimica et Biophysica Acta 1833 (2013) 2279–2292activity may not be sufﬁcient to cleave the entire pool of FRET substrate.
We, therefore, also analyzed our readings for indications of mild,
submaximal FRET probe cleavage by peak-shift analysis. As a ﬁrst im-
portant control, repeat readings of untreated control samples perfectly
overlapped (Fig. 7A), demonstrating the performance stability of the
instrumentation. In a positive control, efﬁcient substrate cleavage in
STS-treated parental MCF-7 cells resulted in a clearly separated peakof completely cleaved substrate (Fig. 7A). No peak shift was detected
inMCF-7 Bcl-xL cells in response to cisplatin, doxorubicin, 5-FU, vincris-
tine or STS (Fig. 7B). In contrast, exposure to death ligands resulted in
mild peak shifts, indicative of submaximal VDVAD probe cleavage,
in the entire population (Fig. 7C). Depletion of caspase-8, but not of
caspase-2, could eliminate these peak shifts in response to TNFα
(Fig. 7D), TRAIL, and FasL (not shown). Consistent with results shown
vehicle
scr
siCasp-8
control
scr
siCasp-8
control
 
%
FR
ET
 n
eg
at
ive
 c
el
ls
0
10
20
vehicle Tnf-α 24 h
scr
siCasp-2
control
scr
siCasp-2
control
 
%
FR
ET
 n
eg
at
ive
 c
el
ls
0
10
20
30
40
50
porin
ctrl kDa
28
proCasp-8
scr siCasp-8
55
vehicle Cisplatin 24 h
scr
siCasp-2
control
scr
siCasp-2
control
vehicle Cisplatin 24 h 
scr
siCasp-8
control
scr
siCasp-8
control
vehicle Vincristine 72 h
scr
siCasp-2
control
scr
siCasp-2
control
vehicle Vincristine 72 h
scr
siCasp-8
control
scr
siCasp-8
control
 
%
FR
ET
 n
eg
at
ive
 c
el
ls
0
10
20
30
40
50
 
%
FR
ET
 n
eg
at
ive
 c
el
ls
0
10
20
 
%
FR
ET
 n
eg
at
ive
 c
el
ls
0
10
20
 
%
FR
ET
 n
eg
at
ive
 c
el
ls
0
10
20
30
40
50
Tnf-α 24 h
MCF-7 Bcl-xL
MCF-7 Bcl-xL
MCF-7 Bcl-xL
MCF-7 Bcl-xL
MCF-7 Bcl-xL
MCF-7 Bcl-xL
A
D
vehicle Cisplatin 24 h
scr
siCasp-2
control
scr
siCasp-2
control
vehicle Cisplatin 24 h 
scr
siCasp-8
control
scr
siCasp-8
control
vehicle Vincristine 72 h
scr
siCasp-2
control
scr
siCasp-2
control
vehicle Vincristine 72 h
scr
siCasp-8
control
scr
siCasp-8
control
 
%
FR
ET
 n
eg
at
ive
 c
el
ls
0
10
20
30
40
50
 
%
FR
ET
 n
eg
at
ive
 c
el
ls
0
10
20
 
%
FR
ET
 n
eg
at
ive
 c
el
ls
 
%
FR
ET
 n
eg
at
ive
 c
el
ls
0
10
20
30
40
50
HCT116  (Bax/Bak)-/- HCT116  (Bax/Bak)-/-
HCT116  (Bax/Bak)-/-HCT116  (Bax/Bak)-/-
porin
ctrl kDa
55
28
proCasp-2
scr siCasp-2
α-tubulin
ctrl kDa
55
proCasp-8
scr siCasp-8
55
porin
ctrl kDa
55
28
proCasp-2
scr siCasp-2
0
10
20
0
10
20
30
40
50
60
FR
ET
 n
eg
at
ive
 c
el
ls
(%
 in
cre
as
e a
bo
ve
 
u
n
tre
at
ed
 c
on
tro
ls)
Cisplatin 5FU
24 48 24 48
MEF Casp-2-/-
MEF wt 
MEF Casp-2-/- Bcl-xL
MEF wt Bcl-xL
24 48 24 48 0
10
20
30
40
50
60
FR
ET
 n
eg
at
ive
 c
el
ls
(%
 in
cre
as
e a
bo
ve
 
u
n
tre
at
ed
 c
on
tro
ls)
Cisplatin 5FU
24 48 24 48 24 48 24 48
proCasp-2 55
kDa
α-tubulin 55
[h] [h]
B
C
E
Casp-2-/-wt
Fig. 6. Complete VDVAD FRET probe cleavage during apoptosis initiation is caspase-2 independent. Cells expressing the VDVAD FRET probe (SCAT-2) were treated with 40 μM cisplatin,
50 μg/mL 5-FU, 25 μg/mL vincristine or 100 ng/mL TNFα as indicated. (A,B) Depletion of caspase-2 does not reduce subpopulationswith cleaved VDVAD FRET probe inMCF-7 Bcl-xL cells
(A) and HCT-116 Bax/Bak deﬁcient cells (B). Immunoblots show effective reduction of caspase-2 protein levels. (C) Loss of caspase-2 does not reduce FRET probe cleavage in wild type
MEFs or MEFs over-expressing RFP-Bcl-xL. Immunoblot conﬁrms loss of caspase-2 in MEF casp-2-/- cells. (D,E) Depletion of caspase-8 reduces subpopulations with cleaved VDVAD FRET
probe in response to TNFα inMCF-7 Bcl-xL cells (D) and to cisplatin and vincristine in response to HCT-116 Bax/Bak deﬁcient cells (E). Immunoblot shows effective reduction of caspase-8
protein levels. All data show means ± s.d. from three parallel cultures. Similar results were obtained in repeat experiments.
2287M.E. Delgado et al. / Biochimica et Biophysica Acta 1833 (2013) 2279–2292in MCF-7 Bcl-xL cells, peak shifts in HCT-116 Bax/Bak deﬁcient cells
were only observed after treatmentwith death ligands (not shown). Re-
cent studies showed that limited glucose supply promotes caspase-2 ac-
tivation and the initiation of apoptosis in Xenopus laevis oocytes [38,39].
DeprivingMCF-7 Bcl-xL or HCT-116Bax/Bak deﬁcient cells of glucose, in
presence or absence of sodium pyruvate, however, did not promote
cisplatin-induced VDVAD cleavage (not shown). Our data, therefore,
indicate a lack of caspase-2-dependent VDVADase activity during apo-
ptosis initiation in all scenarios investigated. Furthermore, we foundthat the limited VDVADase activity observed in cells that cannot
engage the mitochondrial apoptosis pathway is dependent on initiator
caspase-8.
3.4. No indication for VDVADase activity during apoptosis initiation in
response to heat shock
Caspase-2 has been suggested to be activated as the apical caspase in
response to heat shock [40]. However, several subsequent biochemical
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2288 M.E. Delgado et al. / Biochimica et Biophysica Acta 1833 (2013) 2279–2292studies failed to reproduce this ﬁnding [17,41,42]. We, therefore, inves-
tigated whether detectable VDVADase activity manifests in response to
heat shock on the single cell level. Heat shock by transient exposure ofFig. 8. No indication for caspase-2 activity during apoptosis initiation in response to heat
absence of 100 μM zVAD-fmk, and immunoblotting was performed to investigate accumul
induced by HS in parental or Bcl-xL over-expressing MCF-7 cells. Cell death was measured b
tures treated in parallel. Similar results were obtained in 3 independent repeat experiments.
MCF-7 Bcl-xL cells following heat shock. 100 μM zVAD-fmk was added where indicated and d
cultures treated in parallel. Similar results were obtained in 3 independent repeat experim
reduced by caspase-2 depletion. Data are means ± s.d. from n = 3 cultures treated in par
of MCF-7 Bcl-xL cells expressing the VDVAD FRET probe following heat shock. Peaks of trea
or residual VDVADase activity. (G) Absence of FRET probe cleavage in MCF-7 Bcl-xL ce
(see Fig. 7) could be detected in TNFα treated MCF-7 Bcl-xL cells. β-actin served as a loadin
HCT-116 or HCT-116 Bax/Bak deﬁcient cells or (K,L) HeLa or HeLa Bcl-2 cells following hea
pendency of probe cleavage. Data in HCT-116 cells are means ± s.d. from n = 3 cultures
HeLa cells are means ± s.e.m. from n = 4 independent experiments. Peak shift analysis o
FRET probe following heat shock. Peaks of treated cells and control cells perfectly overlap,
of FRET probe cleavage in HeLa Bcl-2 cells following heat shock demonstrated by immunobl
casp-2−/− following heat shock. Over expression of RFP-Bcl-xL, but not loss of caspase-2 r
associated membrane rupture. Data are means ± s.e.m. from at least n = 3 independent eMCF-7 cells to 45 °C provoked the accumulation of heat shock protein
70 (Fig. 8A), and induced cell death in parental MCF-7 cells (Fig. 8B).
Bcl-xL over-expression was fully protective (Fig. 8B), indicating theshock. (A) MCF-7 Bcl-xL cells were heat shocked (HS) for 1 h at 45 °C, in presence or
ation of heat shock protein Hsp-70. β-actin served as a loading control. (B) Cell death
y propidium iodide uptake and ﬂow cytometry. Data are means ± s.d. from n = 3 cul-
(C,D) Quantiﬁcation of VDVADase activity by FRET probe cleavage in parental MCF-7 or
emonstrates caspase dependency of probe cleavage. Data are means ± s.d. from n = 3
ents. (E) FRET probe cleavage in small subpopulations of MCF-7 Bcl-xL cells cannot be
allel. Similar results were obtained in two repeat experiments. (F) Peak shift analysis
ted cells and control cells perfectly overlap, demonstrating the absence of submaximal
lls following heat shock demonstrated by immunoblotting. Residual probe cleavage
g control. Quantiﬁcation of VDVADase activity by FRET probe cleavage in (H,I) parental
t shock. 100 μM zVAD-fmk was added where indicated and demonstrates caspase de-
treated in parallel. Similar results were obtained in two repeat experiments. Data in
f (J) HCT-116 Bax/Bak deﬁcient cells or (M) HeLa Bcl-2 cells expressing the VDVAD
demonstrating the absence of submaximal or residual VDVADase activity. (N) Absence
otting. β-actin served as a loading control. (O,P) FRET probe cleavage in MEF wt or MEF
educed FRET probe cleavage. Values at 48 h were close to zero due to cell death and
xperiments.
2289M.E. Delgado et al. / Biochimica et Biophysica Acta 1833 (2013) 2279–2292requirement of the mitochondrial apoptosis pathway for cell death
execution. Similar results were found at 43 °C and 41 °C; however,
overall responsivenesswas lower (data not shown). Heat shock induced
VDVADase activity in parentalMCF-7 cells (Fig. 8C),whereas only a very
small subpopulationwith cleaved VDVAD FRET probe could be detected
in Bcl-xL over-expressing cells (Fig. 8D). Substrate cleavage in this10
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HCT116subpopulation could not be reduced by caspase-2 depletion (Fig. 8E).
Likewise, no peak shift, indicative of low, submaximal FRET substrate
cleavage, could be seen in heat-shocked MCF-7 Bcl-xL cells (Fig. 8F),
neither could cleaved FRET probe be detected by immunoblotting
(Fig. 8G). Similar results were obtained in HCT-116 Bax/Bak deﬁcient
cells (Fig. 8H–J), HeLa cells over-expressing Bcl-2 (Fig. 8K–N) and inntrol 3 h post HS 24 h post HS
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VDVADase activities were not reduced in caspase-2 deﬁcientMEFs or in
caspase-2 deﬁcient MEFs over-expressing Bcl-xL, when compared to
wild-type controls (Fig. 8O,P). We, therefore, could not ﬁnd any evi-
dence for caspase-2 activation during apoptosis initiation in response
to heat shock.
4. Discussion
Contradictory data on whether caspase-2 is activated in response to
various intrinsic and extrinsic pro-apoptotic stimuli have been reported
in the literature. We therefore conducted a FRET-based screen to non-
invasively detect VDVADase proteolytic activity in these scenarios
directly within living cells. Where VDVADase was detected, targeted
depletions or genetic models lacking individual caspases were used to
identify which caspases contributed to VDVADase activity. The ﬂexibil-
ity of the cleavable linker, the optimized linker length and the close dis-
tance between donor and acceptor ﬂuorophores in this and related
FRET probes ensures very efﬁcient resonance energy transfer and pro-
teolytic cleavage [26], and alsomimics preferred cleavage site in natural
caspase substrates, which are predominantly unstructured surface
loops [43]. FRET-based ratiometric analysis allowed us to measure also
very low amounts of VDVADase activities and incomplete probe cleav-
age. Since we previously demonstrated that as little as 2.5% substrate
cleavage can be detected using such FRET probes [44] and since even
very limited, residual activation of caspase-2 results in efﬁcient probe
cleavage (see Fig. 2), we conclude that caspase-2 activity is insigniﬁcant
or even absent in all scenarios of intrinsic and extrinsic apoptosis inves-
tigated in this study.
Since caspase-2 can be processed by effector caspases-3 and -7 dur-
ing apoptosis execution [14] and since caspase-2 prefers substrate rec-
ognition motifs that are related to those of effector caspases [8], it has
been suggested that caspase-2 could function as an additional effector
caspase during apoptosis execution [30,31]. However, our measure-
ments indicate that the contribution of caspase-2 to VDVADase activity
during apoptosis execution is negligible. During canonical caspase-2
activation, procaspase-2 monomers dimerize at the PIDDosome to
auto-proteolytically mature into the fully processed active caspase-2
heterodimer. In contrast, during apoptosis execution effector caspases
cleave procaspase-2 monomers in absence of a dimerization platform.
The insigniﬁcant contribution of caspase-2 to VDVADase activity during
apoptosis execution may, therefore, indicate a lack of or a limitation in
the formation of active caspase-2 hetero-dimers. This notion is supported
by recent ﬁndings on caspase-8, whose activation likewise depends on
the dimerization of inactive monomers. Like procaspase-2, procaspase-8
can be cleaved by effector caspases and, therefore, has been widely sug-
gested to be proteolytically activated during apoptosis execution in the
past. Recent studies insteadhave shown that procaspase-8 cleavage in ab-
sence of a dimerization platformdoes not result in detectable activity, and
that the poor dimerization of cleaved caspase-8 monomers is crucial to
inhibit an otherwise hypersensitive positive feedback loop between
caspase-8 and effector caspases [45,46]. Quantitative data characterizing
the propensity of processed caspase-2 monomers to dimerize at physio-
logical conditions could further clarify this issue, but unfortunately these
have not been reported yet.
We did not detect caspase-2 activity during apoptosis initiation in re-
sponse to genotoxic stress or microtubule destabilization. Previous stud-
ies either suggested or rejected a role for caspase-2 in these scenarios
(reviewed in [6]). Historically, the processing of procaspases has implic-
itly been equated with activation, which, together with the overlapping
substrate speciﬁcities of caspases and the lack of synthetic inhibitors
and activity assays speciﬁc for individual caspases [12,47], may explain
reports that contradict our ﬁndings. In addition, readouts based on cell
extracts and homogenates carry the risk of artiﬁcially initiating apoptotic
processes. In this context it is noteworthy that PIDDosomes can sponta-
neously form and activate caspase-2 upon cell disruption [48].Caspase-2 has been suggested to be required for the initiation of heat
shock-induced apoptosis [40,49]. Subsequently published biochemical
and cell biological studies, however, failed to conﬁrm or to reproduce
this ﬁnding [17,41,42]. This was contrasted again by another study
which, similar to our strategy, aimed to investigate caspase-2 signaling
in intact, living cells [19]. However, rather than directly measuring
caspase-2 activity, the dimerisation of recombinantly introduced, cata-
lytically inactive caspase-2-based fusion proteins was investigated by
bimolecular ﬂuorescence complementation, and ﬂuorescence emission
was used as a surrogate marker for caspase-2 activation [50]. Over-
expression of such constructs may sensitize to artiﬁcial dimerization,
as demonstrated by ectopic caspase-2 expression previously [9,10,13],
aswell as to spontaneous PIDDosome formation, with the latter process
being temperature sensitive [48]. This experimental approach may,
therefore, be of limited applicability for detecting conditions of physio-
logical caspase-2 activation.
We discussed potential methodological and experimental limitations
of previous studies in context with our ﬁndings above. This may, at least
to some extent, explain the contradictory conclusions in the published
literature on whether caspase-2 is activated in various scenarios of
apoptosis induction. It can also be speculated that additional, currently
unknown mechanisms could exist which regulate or restrict the access
of substrates to the caspase-2 catalytic cleft. Furthermore, data obtained
fromexperiments inXenopus laevis oocyte extracts indicate an additional
layer of metabolic control that regulates caspase-2 activation through
the pentose phosphate pathway, and initial data from mammalian cells
suggest this could be relevant also in human systems [38,39]: Phosphor-
ylation of caspase-2 by calcium/calmodulin-dependent protein kinase II
in nutrient rich environments suppresses caspase-2 activation, and the
association of 14-3-3ζ with caspase-2 prevents the de-phosphorylation
of the latter. Similarly, the mitosis-promoting kinase cdk1-cyclin B1
phosphorylates caspase-2 and suppresses its activation during mitosis
[51]. At least in context with genotoxic drug induced apoptosis, our
experiments instead showed that glucose deprivation did not induce or
enhance caspase-2 activation or VDVADase activities in our model sys-
tems. However, it is possible that differences in cell culturing conditions,
cellular proliferation rates or differences between transformed and non-
transformed cells underlie such differential susceptibilities for caspase-2
activation. A systematic analysis of the multi-factorial interplay between
nutrient supply, metabolism, and cellular susceptibility for caspase-2
activation therefore seems warranted, and a large scale screening
approach, based on the methodological framework described here,
may assist such efforts.
Importantly, we do not rule out the contribution of caspase-2 to
cell death regulation but conclude that caspase-2 proteolytic activity
is not established or insigniﬁcant during apoptosis initiation at the
conditions investigated here. Another intriguing possibility therefore
is that caspase-2 has functions which are independent of its enzymatic
activity. Evidence for this possibilitywas recently published, demonstrat-
ing that caspase-2 can drive p21 translation in response to DNA damage
without the need for proteolytic activity [34]. While the debate on the
role of caspase-2 in various physiological and pathophysiological scenar-
ios, such as host–pathogen interactions, DNA-damage responses, mitotic
catastrophe, aging, metabolism, and tumor suppression, continues [52],
activity-independent functions of caspase-2 have not been systematical-
ly investigated in these circumstances. Reconstituting caspase-2 deﬁ-
cient model systems with inactive or dimerisation-deﬁcient variants
therefore could provide important insight into activity-independent
roles of caspase-2 both in cellulo and in vivo.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2013.05.025.
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